+987.9%
MRNA vs NVMI
-11.6%
+999.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NVMI | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -2.4% | +15.5% | +13.6% |
| 7D | +20.6% | -11.8% | +32.4% | +23.7% |
| 30D | +27.1% | -24.8% | +52.0% | +34.1% |
| 3M | +353.4% | -28.6% | +382.0% | +383.3% |
| 6M | +446.3% | -40.0% | +486.3% | +480.0% |
| YTD | +776.2% | -10.1% | +786.2% | +689.7% |
| 1Y | +987.9% | -9.8% | +997.7% | +875.1% |
| All | +987.9% | -11.6% | +999.5% | +875.1% |
Cumulative growth
Daily Returns
Daily percentage return beside NVMI.
Daily Out/Under-Performance
Portfolio return minus NVMI return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NVMI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NVMI wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling